{"id":"W2050963273","doi":"10.1038/ncprheum0340","title":"Strategies to control disease in rheumatoid arthritis with tumor necrosis factor antagonists—an opportunity to improve outcomes","year":2006,"lang":"en","type":"review","venue":"Nature Clinical Practice Rheumatology","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto","funders":"F. Hoffmann-La Roche; Amgen","keywords":"Medicine; Rheumatoid arthritis; Disease; Methotrexate; Antirheumatic Agents; Arthritis; Antirheumatic drugs; Biologic Agents; Intensive care medicine; Physical therapy; Oncology; Immunology; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.002287818,0.001405364,0.007881206,0.0009088308,0.0002571317,0.0004461546,0.0009269948,0.00171262,0.0002971482],"category_scores_gemma":[0.04157207,0.001027245,0.001001063,0.0008759944,0.0005763483,0.001041061,0.0002689589,0.006814628,0.0003460045],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002752906,"about_ca_system_score_gemma":0.007420504,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001099616,"about_ca_topic_score_gemma":0.001699039,"domain_scores_codex":[0.9884475,0.002714273,0.003769264,0.002170496,0.001220897,0.001677606],"domain_scores_gemma":[0.9795274,0.01201302,0.001376164,0.001948401,0.0008132535,0.004321746],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.006177752,0.004056594,0.01261341,0.00444561,0.001538976,0.006263135,0.0001248698,0.000002648494,0.00000113071,0.003655649,0.006027399,0.9550928],"study_design_scores_gemma":[0.006031123,0.002782629,0.002931102,0.01334326,0.0001530833,0.00148876,0.000247298,0.000008799924,3.458648e-7,0.0001468109,0.9717426,0.001124158],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.003152428,0.9792549,0.0001947942,0.008184639,0.001308514,0.006016042,0.001146756,0.0002800361,0.0004618789],"genre_scores_gemma":[0.01306967,0.9778709,0.003021156,0.004163651,0.0001177867,0.0009528008,0.0004377961,0.0002533938,0.0001128544],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9657152,"threshold_uncertainty_score":0.9998696,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04107863238858146,"score_gpt":0.4316568258980713,"score_spread":0.3905781935094898,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}